Home / Business and Economy / Intuitive Surgical Stock Plummets Despite Solid Results
Intuitive Surgical Stock Plummets Despite Solid Results
2 Jun
Summary
- ISRG stock has dropped 29.7% from its 52-week high.
- Growth concerns and competition impact ISRG's stock performance.
- Analysts suggest a 36.8% upside potential for ISRG.
Intuitive Surgical, Inc. (ISRG), a prominent medical technology firm headquartered in Sunnyvale, California, is renowned for pioneering robotic-assisted surgery. Its da Vinci Surgical System is globally recognized for enhancing minimally invasive procedures across various surgical specialties.
As of June 2, 2026, ISRG's market capitalization stands at $175.4 billion, classifying it as a large-cap stock. Despite its substantial market presence, the company's stock has experienced a notable downturn.
The stock has retreated 29.7% from its 52-week high of $603.88, reached on January 7, 2026. Over the past three months, ISRG shares have declined by 15.7%, underperforming the healthcare sector's performance.
Year-to-date and over the past year, ISRG has also underperformed its sector benchmark. This trend is attributed to investor concerns regarding decelerating growth, valuation pressures, and heightened competition within the robotic surgery market.
Despite these headwinds, 30 analysts covering ISRG maintain a consensus 'Moderate Buy' rating. The average price target of $580.81 indicates an estimated 36.8% potential upside from its current trading levels.
